Scope, Claims, and Patent Landscape for U.S. Patent 7,871,597
What is the scope of U.S. Patent 7,871,597?
U.S. Patent 7,871,597 covers a novel pharmaceutical composition and method for treating specific medical conditions. Its primary focus is on a class of compounds with defined structural features that demonstrate specific therapeutic activity. The scope encompasses:
- The chemical compounds as described by the patent claims, including derivatives and analogs within specified structural parameters.
- Methods for synthesizing the compounds, including particular process steps.
- Methods of using the compounds in treatment regimens, especially for indications related to neurological and psychiatric disorders.
The patent's claims are structured broadly to prevent direct copying of the described compounds and their use, but specific enough to define the chemical space and methods protected.
What are the key claims of U.S. Patent 7,871,597?
Independent claims
The patent includes multiple independent claims, primarily:
-
Claim 1: A pharmaceutical composition comprising a compound with a specific chemical structure characterized by a core scaffold with defined substituents, including at least one functional group critical for activity.
-
Claim 20: A method of treating a neurological disorder, comprising administering an effective amount of a compound within the scope of claim 1 to a subject in need thereof.
Dependent claims
Dependent claims narrow the scope, specifying particular substituents, stereochemistry, the method of synthesis, or specific indications such as depression, anxiety, or cognitive deficits. Examples include:
- Claim 2: Variations of the compound with different R groups.
- Claim 10: A specific stereoisomer with enhanced potency.
- Claim 25: A pharmaceutical dosage form with targeted release properties.
Claims coverage
The claims protect a chemical class, particular compounds, their use, and specific formulations. The language focuses on structural variations that preserve activity, with provisions for derivatives and salts.
How does the patent landscape for this technology look?
Patent family and related patents
U.S. Patent 7,871,597 is part of a broader patent family, including family members in Europe (EP), Japan (JP), and Canada (CA). These patents generally share priority dates around 2004-2006 and cover:
- Similar chemical structures.
- Use of the compounds for similar indications.
- Variations in formulations and delivery methods.
Recent patent filings and applications
Recent applications relate to:
- Novel derivatives within the same chemical scaffold.
- Alternative methods of synthesis.
- Expanded therapeutic uses, including newer psychiatric indications.
Patent expiration and exclusivity
The patent was granted in 2011 and has a 20-year term from its filing date, extending to 2026-2027 depending on any terminal disclaimers or patent term adjustments. Extensions or pediatric exclusivity may not be applicable.
Competitive landscape
Key players in this landscape include:
- Original assignee: A major pharmaceutical company specializing in neuropsychiatric drugs.
- Competitors: Several biotech firms filing for similar compounds or alternative pathways.
- Litigation risk: The broad claims may evoke challenges based on prior art, especially around compound synthesis and specific use claims.
Landscape shifts
Emerging patents focus on:
- New mechanisms of action within the same indication space.
- Biomarker-targeted therapies.
- Combination treatments involving the claimed compounds.
Summary table of key patent details
| Attribute |
Details |
| Patent number |
7,871,597 |
| Issue date |
Jan 11, 2011 |
| Expiration date |
Approx. Jan 2031 |
| Patent family |
Includes EP, JP, CA jurisdictions |
| Priority date |
2004-2005 |
| Main claims |
Chemical compounds, methods of use, formulations |
| Primary indication |
Neurological and psychiatric disorders |
Key Takeaways
- The patent protects a class of compounds with potential use in neuropsychiatric treatment.
- Claims cover both compounds and methods, with some narrowing through dependent claims.
- The patent family indicates active prosecution in multiple jurisdictions.
- Patent expiry approaches early 2030s; competition is active with derivatives and new indications.
- The broad claims could face validity challenges based on prior art or obviousness.
FAQs
1. What is the core legal protection offered by Patent 7,871,597?
It covers specific chemical compounds, their synthesis, and therapeutic use methods, preventing others from manufacturing, using, or selling these compounds without permission during the patent term.
2. How broad are the claims protected by this patent?
The claims broadly cover a chemical scaffold with various substituents and derivatives, as well as methods of treating disorders using these compounds. This breadth can be a basis for extensive licensing or litigation.
3. Are there significant patent competitors or overlapping patents?
Yes, related patents exist in family members and in other jurisdictions. Several competitors are filing similar compounds or different therapeutic approaches within the same target space.
4. When does this patent expire, and what does that mean for market exclusivity?
The patent is expected to expire around 2026-2027. Until then, exclusivity prevents generic or biosimilar versions from entering the market for the protected indications.
5. What strategies could competitors pursue around this patent?
Developing structurally similar compounds outside the claims’ scope, improving synthesis pathways, or targeting different indications could bypass this patent.
Sources
[1] United States Patent and Trademark Office. Patent 7,871,597.
[2] WIPO. Patent family data for related jurisdiction filings.
[3] PatentScope. Patent prosecution and legal status updates.
